Janus Henderson Group PLC
- SEC CIK
- 0001274173
- Latest filing
- May 18, 2026
MDGL holding history
Madrigal Pharmaceuticals, Inc. in every 13F filed by Janus Henderson Group PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDGL overviewAll 13F holders of MDGLFull Q1 2026 holdings
- Shares (Q1 2026)
- 2,018,647
- Value
- $1.05B
- % of portfolio
- 0.5%
- Quarters held
- 15
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 2,018,647 | $1.05B | 0.5% | +433,804+27.4% | Added | Holders |
| Q4 2025 | 1,584,843 | $918.2M | 0.4% | −257,847−14.0% | Reduced | Holders |
| Q3 2025 | 1,842,690 | $845.3M | 0.4% | −349,063−15.9% | Reduced | Holders |
| Q2 2025 | 2,191,753 | $663.3M | 0.3% | −14,096−0.6% | Reduced | Holders |
| Q1 2025 | 2,205,849 | $723.1M | 0.4% | −2,545−0.1% | Reduced | Holders |
| Q4 2024 | 2,208,394 | $681.4M | 0.3% | −269,766−10.9% | Reduced | Holders |
| Q3 2024 | 2,478,160 | $525.9M | 0.3% | −7,591−0.3% | Reduced | Holders |
| Q2 2024 | 2,485,751 | $696.3M | 0.4% | −115,531−4.4% | Reduced | Holders |
| Q1 2024 | 2,601,282 | $694.5M | 0.4% | −300,768−10.4% | Reduced | Holders |
| Q4 2023 | 2,902,050 | $671.5M | 0.4% | −140,611−4.6% | Reduced | Holders |
| Q3 2023 | 3,042,661 | $444.3M | 0.3% | +1,558,535+105.0% | Added | Holders |
| Q2 2023 | 1,484,126 | $342.8M | 0.2% | +1,108,452+295.1% | Added | Holders |
| Q1 2023 | 375,674 | $91.0M | 0.1% | +193,026+105.7% | Added | Holders |
| Q4 2022 | 182,648 | $53.0M | <0.1% | +96,265+111.4% | Added | Holders |
| Q3 2022 | 86,383 | $5.61M | <0.1% | +86,383 | New | Holders |